Samir Narayan

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi An electronic application for rapidly calculating Charlson comorbidity score
    William H Hall
    University of California, Davis, Department of Radiation Oncology, UC Davis Cancer Center, 4501 X Street, G126, Sacramento, CA 95817, USA
    BMC Cancer 4:94. 2004
  2. ncbi Multimodality therapy for Pancoast tumor
    Samir Narayan
    Department of Radiation Oncology, University of California Davis Health System, 4501 X Street, Sacramento, CA 95817, USA
    Nat Clin Pract Oncol 3:484-91. 2006
  3. ncbi Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer
    Samir Narayan
    Department of Radiation Oncology, University of California Davis Medical Center, 4501 X Street, G126, Sacramento, CA 95817, USA
    Lung Cancer 44:79-88. 2004
  4. ncbi The use of intensity-modulated radiation therapy in the treatment of oropharyngeal carcinoma
    Samir Narayan
    Department of Radiation Oncology, University of California Davis Health System, 4501 X Street, G155 Sacramento, CA 95817, USA
    Curr Opin Otolaryngol Head Neck Surg 13:226-32. 2005
  5. ncbi Combined modality treatment for prostate cancer: role of chemotherapy
    Howard M Sandler
    Department of Radiation Oncology, University of Michigan Medical School, 1500 E. Medical Center Drive, UH B2C490, Ann Arbor, MI 48109-0010, USA
    Semin Oncol 30:95-100. 2003
  6. ncbi Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy
    Samir Narayan
    Department of Radiation Oncology, University of California Davis Medical Center, Sacramento, CA, USA
    Int J Radiat Oncol Biol Phys 72:756-62. 2008
  7. ncbi Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer
    William H Hall
    Department of Radiation Oncology, University of California, Davis, Cancer Center, Sacramento, CA, USA
    Int J Radiat Oncol Biol Phys 72:1362-7. 2008
  8. ncbi Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer
    Chunhui Luo
    Radiation Oncology, University of California Davis Medical Center, Sacramento, CA 95817, USA
    Int J Radiat Oncol Biol Phys 66:1253-62. 2006
  9. ncbi Comparison of intensity-modulated radiotherapy using helical tomotherapy and segmental multileaf collimator-based techniques for nasopharyngeal carcinoma: dosimetric analysis incorporating quality assurance guidelines from RTOG 0225
    Allen M Chen
    Departments of Radiation Oncology, University of California Davis Cancer Center, 4501 X Street, Suite G140, Sacramento, CA, USA
    Technol Cancer Res Treat 9:291-8. 2010
  10. ncbi A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer
    Henry Wang
    Davis Cancer Center, University of California and Veterans Administration, Northern California Health System, Sacramento, CA 95817, USA
    J Thorac Oncol 2:153-7. 2007

Detail Information

Publications15

  1. ncbi An electronic application for rapidly calculating Charlson comorbidity score
    William H Hall
    University of California, Davis, Department of Radiation Oncology, UC Davis Cancer Center, 4501 X Street, G126, Sacramento, CA 95817, USA
    BMC Cancer 4:94. 2004
    ..Unfortunately, the use of such scales has yet to be widely integrated into either clinical practice or clinical trials research...
  2. ncbi Multimodality therapy for Pancoast tumor
    Samir Narayan
    Department of Radiation Oncology, University of California Davis Health System, 4501 X Street, Sacramento, CA 95817, USA
    Nat Clin Pract Oncol 3:484-91. 2006
    ..Future potential areas of investigation, including the role of surgery for patients with N2-positive disease and the use of imaging to assess response after induction therapy, are discussed...
  3. ncbi Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer
    Samir Narayan
    Department of Radiation Oncology, University of California Davis Medical Center, 4501 X Street, G126, Sacramento, CA 95817, USA
    Lung Cancer 44:79-88. 2004
    ..The results of patients treated to either 92.4 or 102.9 Gy are reported...
  4. ncbi The use of intensity-modulated radiation therapy in the treatment of oropharyngeal carcinoma
    Samir Narayan
    Department of Radiation Oncology, University of California Davis Health System, 4501 X Street, G155 Sacramento, CA 95817, USA
    Curr Opin Otolaryngol Head Neck Surg 13:226-32. 2005
    ..Intensity-modulated radiation therapy is a relatively new, advanced form of radiation therapy that is being studied in an effort to improve local control rates and minimize the late effects of treatment...
  5. ncbi Combined modality treatment for prostate cancer: role of chemotherapy
    Howard M Sandler
    Department of Radiation Oncology, University of Michigan Medical School, 1500 E. Medical Center Drive, UH B2C490, Ann Arbor, MI 48109-0010, USA
    Semin Oncol 30:95-100. 2003
    ..The role of chemotherapy for patients with nonmetastatic, hormone-naive prostate cancer will be discussed...
  6. ncbi Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy
    Samir Narayan
    Department of Radiation Oncology, University of California Davis Medical Center, Sacramento, CA, USA
    Int J Radiat Oncol Biol Phys 72:756-62. 2008
    ..The main objective is to establish a quantitative dose response for clinical oral mucositis...
  7. ncbi Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer
    William H Hall
    Department of Radiation Oncology, University of California, Davis, Cancer Center, Sacramento, CA, USA
    Int J Radiat Oncol Biol Phys 72:1362-7. 2008
    ....
  8. ncbi Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer
    Chunhui Luo
    Radiation Oncology, University of California Davis Medical Center, Sacramento, CA 95817, USA
    Int J Radiat Oncol Biol Phys 66:1253-62. 2006
    ..We use these standards as well as differences in individual cases to make decisions on whether patients may benefit from IMRT treatment rather than 3D-CRT...
  9. ncbi Comparison of intensity-modulated radiotherapy using helical tomotherapy and segmental multileaf collimator-based techniques for nasopharyngeal carcinoma: dosimetric analysis incorporating quality assurance guidelines from RTOG 0225
    Allen M Chen
    Departments of Radiation Oncology, University of California Davis Cancer Center, 4501 X Street, Suite G140, Sacramento, CA, USA
    Technol Cancer Res Treat 9:291-8. 2010
    ..02), larynx (p = 0.03), and oral cavity (p = 0.03). These findings suggest that HT-IMRT may be of improve the therapeutic ratio in the radiotherapeutic treatment of nasopharyngeal carcinoma...
  10. ncbi A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer
    Henry Wang
    Davis Cancer Center, University of California and Veterans Administration, Northern California Health System, Sacramento, CA 95817, USA
    J Thorac Oncol 2:153-7. 2007
    ..We conducted a phase II clinical trial of concurrent paclitaxel, carboplatin, and radiation with or without surgery as an alternative to the standard cisplatin-based CRT for localized and metastatic esophageal cancer...
  11. ncbi Introducing new technologies into the clinic
    Srinivasan Vijayakumar
    Department of Radiation Oncology, University of California, Davis Cancer Center, Sacramento, CA 95417, USA
    Front Radiat Ther Oncol 40:180-92. 2007
    ..These concepts, applied in prostate cancer in this communication, have wider applications in other disease sites and in the introduction of technologies beyond intensity-modulated radiation therapy...
  12. ncbi Integration of novel therapeutics into combined modality therapy of locally advanced non-small cell lung cancer
    David Gandara
    Department of Internal Medicine, Division of Hematology Oncology and Department of Radiation Oncology, UC Davis Cancer Center, University of California Davis Medical Center, 4501 X Street, Sacramento, CA 95817, USA
    Clin Cancer Res 11:5057s-5062s. 2005
    ..Here, we describe conceptual issues, preclinical rationale, and ongoing or planned clinical trials incorporating NTAs into current treatment paradigms for unresectable stage III NSCLC...
  13. ncbi Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma
    Samir Narayan
    Department of Radiation Oncology, University of Michigan Health Care System, Ann Arbor, MI 48109, USA
    Int J Radiat Oncol Biol Phys 56:537-43. 2003
    ..We assessed visual outcomes, local control, and toxicity associated with three-dimensional conformal radiation therapy (3D-CRT) for primary optic nerve sheath meningiomas (ONSM)...
  14. ncbi Palliative radiation therapy for head and neck cancer: toward an optimal fractionation scheme
    Allen M Chen
    Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, California 95817, USA
    Head Neck 30:1586-91. 2008
    ..To analyze the efficacy of various fractionation schedules for the palliation of head and neck cancer with radiation therapy...
  15. ncbi Chemotherapy for localized, high-risk prostate cancer
    Samir Narayan
    Department of Radiation Oncology, University of Michigan Health System, Ann Arbor, MI 48109-0010, USA
    Semin Radiat Oncol 13:152-7. 2003
    ..The role of chemotherapy in the nonmetastatic prostate, hormone-naïve prostate cancer patient will be discussed...